ASX Stock

At Trader Dealer we understand the importance of information. You can use our handy company information finder to get key fundamental data about any company listed on the ASX.

Simply enter the stock code or the name of the company you are interested in for ASX share price information, company size, research analyst forecast, share and financial ratios, as well as a business and financial summary.

Don’t know the ASX code of the stock you want? Just click on the letter below for a full alphabetical listing.


Enter ASX Stock Code

Bookmark Page !



View all Companies by Letters

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 


 
 

CSL Limited
Industry Group: Biotechnology - Biotechnology & Drugs

Trade Online with Trader Dealer

Sorry, No Chart Available.

Business Summary
CSL Limited is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. The Company operates in three segments. CSL Behring manufactures markets and develops plasma products. Intellectual Property Licensing is engaged in the licensing of Intellectual Property generated by the Company’s to unrelated third parties. Other Human Health comprises CSL Bioplasma and CSL Biotherapies. These businesses manufacture and distribute biotherapeutic products and are disclosed in aggregate as they exhibit similar economic characteristics. CSL Limited operates in four geographic areas: Australia, the United States of America, Switzerland and Germany. Its subsidiaries include CSL Employee Share Trust, CSL Biotherapies Pty Ltd, Iscotec AB, Amrad Pty Ltd, CSL Finance Pty Ltd, CSL Behring AG, CSL UK Holdings Limited, CSLB Holdings Inc, CSL Behring LLC and CSL Behring S.A. de C.V.

Financial Summary
BRIEF: For the fiscal year ended 30 June 2010, CSL Limited's revenues decreased 8% to A$4.63B. Net income decreased 8% to A$1.05B. Revenues reflect a decrease in income from CSL Behring segment of the group. Net income also reflects increased selling & marketing expense, higher research & development expenses and the absence of other income. CSL Limited is engaged in the development and manufacture of vaccines.

Business Address
Mark Dehring
Investors Relation
45 Poplar Road
Victoria, VIC 3052
Phone: 61-3-93891911
Fax: 61-3-93891434
http://www.csl.com.au/

ASX Share Price Information
Current Price 33.25
Current Price Date 07/09/2010
52 Week Hi/Low 37.56 - 30.03
Avg Volume Last ten Days 2.63
ASX Company Sizing
Market Cap 18277.29
Revenues 17738.43
EBITDA 1554.23
Net Income 1052.90
Number of Employees 9992
Enterprise Value 17738.43
Research Analyst Forecast
Consensus Recommendation Outperform
Target Price 35.51521
LT Growth Rate 11.9370
Projected P/E 17.27730
Sales 4585.67130
EPS 1.92449
Profit 1352.22640
DPS 0.86018
Share Ratios
EPS 1.85186
RPS 8.13796
BV per Share 7.66827
Cash per Share 1.82112
Cashflow per Share 2.12732
Cashflow per Share 0.80000
Financial Ratios
Gross Margin 50.96639
ROE 21.75845
Price/Sales 3.95019
P/E 17.95492
P/Book 4.33605